Poster
Detecting endogenous protein interactions and RIPTACs – TPD & Induced Proximity Summit – Boston 2026
Protein -protein interactions (PPIs) are fundamental drivers of cellular function. When dysregulated, they can contribute to the development of diseases, including cancer, neurodegenerative disorders, and autoimmune conditions, making PPIs compelling therapeutic targets. Among emerging therapeutic strategies, induced proximity is rapidly gaining traction as a novel method for modulating disease biology. Regulation Induced Proximity Targeting Chimeras (RIPTACs) leverage this concept through a "hold-and -kill" mechanism, driving the formation of a stable complex between a disease -associated target protein and an essential effector protein. By disrupting the effector protein's function, this induced interaction can ultimately alter the disease state under investigation. Measuring endogenous PPIs and induced ternary complexes within native cellular environments has long posed technical challenges. The AlphaLISA SureFire®platform solves this by providing direct detection of protein interactions in endogenous cell systems.